285 related articles for article (PubMed ID: 30235455)
1. Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome.
Melenovsky V; Cervenka L; Viklicky O; Franekova J; Havlenova T; Behounek M; Chmel M; Petrak J
Kidney Blood Press Res; 2018; 43(5):1437-1450. PubMed ID: 30235455
[TBL] [Abstract][Full Text] [Related]
2. Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure.
Cohen-Segev R; Francis B; Abu-Saleh N; Awad H; Lazarovich A; Kabala A; Aronson D; Abassi Z
Acta Histochem; 2014 Oct; 116(8):1342-9. PubMed ID: 25217176
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
4. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling.
Zhang MJ; Gu Y; Wang H; Zhu PF; Liu XY; Wu J
Eur Rev Med Pharmacol Sci; 2016; 20(2):345-54. PubMed ID: 26875907
[TBL] [Abstract][Full Text] [Related]
5. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.
Schunkert H; Ingelfinger JR; Hirsch AT; Tang SS; Litwin SE; Talsness CE; Dzau VJ
J Clin Invest; 1992 Oct; 90(4):1523-9. PubMed ID: 1401084
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J
Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375
[TBL] [Abstract][Full Text] [Related]
7. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
Giam B; Kaye DM; Rajapakse NW
Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
[TBL] [Abstract][Full Text] [Related]
9. The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Triposkiadis F; Starling RC; Boudoulas H; Giamouzis G; Butler J
Heart Fail Rev; 2012 May; 17(3):355-66. PubMed ID: 22086438
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome in acute heart failure: a vicious cycle?
Caetano F; Barra S; Faustino A; Botelho A; Mota P; Costa M; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):139-46. PubMed ID: 24642129
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
13. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
14. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
15. Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome: insight from studies with Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
Honetschlägerová Z; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Táborský M; Vaňourková Z; Kujal P; Červenka L
Hypertens Res; 2024 Apr; 47(4):998-1016. PubMed ID: 38302775
[TBL] [Abstract][Full Text] [Related]
16. The role of the kidney in heart failure.
Metra M; Cotter G; Gheorghiade M; Dei Cas L; Voors AA
Eur Heart J; 2012 Sep; 33(17):2135-42. PubMed ID: 22888113
[TBL] [Abstract][Full Text] [Related]
17. Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and
Jíchová Š; Gawryś O; Kompanowska-Jezierska E; Sadowski J; Melenovský V; Hošková L; Červenka L; Kala P; Veselka J; Čertíková Chábová V
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445179
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
19. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
